Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Polman

Showing results (211-220 of 290) with videos related to

Pageof 29
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 22, 2010
Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?L V A E Bosma, J J Kragt, L Brieva, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 18, 2002
The INTERMED: a screening instrument to identify multiple sclerosis patients in need of multidisciplinary treatmentE L J Hoogervorst, P de Jonge, B Jelles, et al.
Magnetic Resonance Imaging|January 1, 1997
Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesionsJ H van Waesberghe, J A Castelijns, P Scheltens, et al.
Neurology|April 10, 2002
Seasonal variation in immune measurements and MRI markers of disease activity in MSJ Killestein, M H G Rep, J F Meilof, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 11, 2001
The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practiceJ B Boringa, R H Lazeron, I E Reuling, et al.
Brain : a Journal of Neurology|June 16, 2001
T(1) hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatmentF Barkhof, J H van Waesberghe, M Filippi, et al.
Neurology|October 6, 2010
Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MSL F van der Voort, A Vennegoor, A Visser, et al.
Journal of the Neurological Sciences|June 1, 1993
4-Aminopyridine induces functional improvement in multiple sclerosis patients: a neurophysiological studyH A van Diemen, C H Polman, M M van Dongen, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|June 9, 2004
Polymorphisms in the genes encoding interferon-gamma and interferon-gamma receptors in multiple sclerosisH M Schrijver, T Hooper-van Veen, M J van Belzen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 18, 2006
Axon loss is an important determinant of weakness in multifocal motor neuropathyJ T H Van Asseldonk, L H Van den Berg, S Kalmijn, et al.
Pageof 29

Showing results (211-220 of 290) with videos related to

Sort By:
Pageof 29
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 22, 2010
Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?L V A E Bosma, J J Kragt, L Brieva, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 18, 2002
The INTERMED: a screening instrument to identify multiple sclerosis patients in need of multidisciplinary treatmentE L J Hoogervorst, P de Jonge, B Jelles, et al.
Magnetic Resonance Imaging|January 1, 1997
Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesionsJ H van Waesberghe, J A Castelijns, P Scheltens, et al.
Neurology|April 10, 2002
Seasonal variation in immune measurements and MRI markers of disease activity in MSJ Killestein, M H G Rep, J F Meilof, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 11, 2001
The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practiceJ B Boringa, R H Lazeron, I E Reuling, et al.
Brain : a Journal of Neurology|June 16, 2001
T(1) hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatmentF Barkhof, J H van Waesberghe, M Filippi, et al.
Neurology|October 6, 2010
Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MSL F van der Voort, A Vennegoor, A Visser, et al.
Journal of the Neurological Sciences|June 1, 1993
4-Aminopyridine induces functional improvement in multiple sclerosis patients: a neurophysiological studyH A van Diemen, C H Polman, M M van Dongen, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|June 9, 2004
Polymorphisms in the genes encoding interferon-gamma and interferon-gamma receptors in multiple sclerosisH M Schrijver, T Hooper-van Veen, M J van Belzen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 18, 2006
Axon loss is an important determinant of weakness in multifocal motor neuropathyJ T H Van Asseldonk, L H Van den Berg, S Kalmijn, et al.
Pageof 29